DERM Stock Doubles in a Month on Lebrikizumab’s Buzz
DERM stock investors are getting excited and for good reason too. Dermira (NASDAQ:DERM) released positive progress for a key drug candidate, lebrikizumab, back in mid-March and shares have been climbing since. Since March 15th, DERM stock ... [Read]
TetraGenetics and ImmunoPrecise Extend Collaboration by Signing Multi-Target Service Agreement for the Discovery of Therapeutic Antibodies
VICTORIA, April 9, 2019 /CNW/ – ImmunoPrecise (TSX:IPA)(OTC:IPATF)(FRA: TQB2)(the “Company” or “IPA”) is pleased to announce the extension of its collaboration with TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimmune diseases. The alliance is focused ... [Read]
CHK Stock: Chesapeake Energy Keeps Up with Crude Oil Prices
All seems well right now for CHK stock, which, last year, plunged dangerously. To be sure, Chesapeake Energy Corporation (NYSE:CHK) shares lost 47% of their value when the price of crude oil tanked. However, CHK ... [Read]
Penny Stocks in Oil: AMR is Rebounding Fast, Up 26% Today!
Houston’s oil and gas company, Alta Mesa Resources (NASDAQ:AMR), is on the rise, climbing 26.42% on the NASDAQ exchange and selling for $0.28 USD at present. This penny stock is cheaper than a stamp at ... [Read]
Penny Stocks to Watch: Is Office Depot too Risky?
Office Depot (NASDAQ:ODP) is a retailing penny stocks company that dropped significantly in yesterday’s trade. Dropping from $3.77 USD to its current price of $2.86 USD, investors have clearly been shaken. Retailers are facing a ... [Read]
ZYNE Stock Zooms Over 50% This Week, What Next for Zynerba?
ZYNE stock continued to gain momentum in Friday’s session and was recently moving up by 10.36% to $8.53 USD, extending its winning streak for the fourth straight session. Shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE) are up ... [Read]
ACHN Stock Climbs After Achillion Pharmaceuticals’ Trial Fills Up
ACHN stock is one of the top performing biotech stocks so far in 2019. Shares of Achillion Pharmaceuticals (NASDAQ:ACHN) are up over 115% since early January amid several key clinical updates. In Wednesday’s session, Achillion ... [Read]
Penny Stocks: Is ARC Document Solutions Undervalued Right Now?
Selling for $2.26 USD on the NYSE, the ARC penny stock could be a consideration for your portfolio. Small-capped companies do bring more risk when investing but that low buy-in price is quite attractive. We’re ... [Read]
ImmunoPrecise Antibodies Leverages Proprietary Technology and Expertise to Create Talem Therapeutics
VICTORIA, April 4, 2019 /CNW/ – ImmunoPrecise (TSX:IPA)(OTC:IPATF)(FRA: TQB2) announces it has formed a wholly-owned, Cambridge, Massachusetts-based subsidiary, Talem Therapeutics (Talem). Talem is focused on the discovery and development of next-generation, fully-human, monoclonal therapeutic antibodies targeting neurology, immuno-oncology, gastroenterology, ... [Read]
Universal mCloud Augments Oil & Gas Workers with Head-Worn, Hands-Free Mobile Connectivity
mCloud to connect oil and gas field workers using its AssetCare™ platform via head-worn, hands-free smart glasses Enterprise applications aim to improve the productivity and efficiency of over 1.4 million field workers operating over 500,000 ... [Read]